Related Experiment Video
Updated: Aug 15, 2026

Murine Kidney Transplant Technique
Published on: October 20, 2015
Renal transplantation: the present and the future
1Division of Pediatric Nephrology, University of Florida College of Medicine, Gainesville, FL, USA. vikasmd@peds.ufl.edu
Insights
Pediatric kidney transplant outcomes now match adult results due to advanced immunosuppression. However, increased infections drive a shift towards minimization protocols for better pediatric patient and graft survival.
Area of Science:
- Pediatric Nephrology
- Transplantation Immunology
- Organ Transplantation
Background:
- Modern pediatric kidney transplantation in developed nations yields excellent results.
- Graft and patient survival rates in children now closely mirror those of adult recipients.
- Kidneys from deceased donors no longer demonstrate significantly inferior outcomes.
Observation:
- Significant advancements in immunosuppressive agents and combination therapies have driven these improvements.
- A notable consequence of potent immunosuppression is an increased incidence of post-transplant infections.
- The transplant community is actively exploring immunosuppression minimization protocols.
Findings:
- Minimization protocols aim to mitigate adverse medication effects and reduce infection rates.
- Novel diagnostic methods for acute rejection and immunosuppression monitoring are emerging.
- DNA-based viral surveillance is transforming clinical practice in pediatric transplantation.
Implications:
- These evolving strategies enhance the safety and efficacy of pediatric kidney transplants.
- Future innovations like stem cell therapy, tissue engineering, and xenotransplantation hold promise.
- Continued research is crucial for optimizing long-term outcomes in pediatric organ recipients.
Abstract:
Children receiving kidney transplants in the modern era in developed countries have excellent overall results. Graft survival and patient survival in children is now virtually equal to that in adult organ recipients. Deceased donor source kidneys are no longer associated with significantly inferior outcomes. These advances are in large part due to development in more potent immunosuppressive agents and newer combinations. These advances have also come at a price in the form of increased post-transplant infections. The transplant community is now moving to minimization protocols to reduce the adverse effects of many of the medications and to reduce the incidence of infections. Newer techniques of diagnosis of acute rejection, degree of immunosuppression and DNA-based viral surveillance are changing the face of clinical practice. Newer technologies such as stem cell transplantation, tissue engineering and xenotransplantation promise even more changes in the future.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

